*Department of Otolaryngology and Head and Neck Surgery; and †Department of Diagnostic Imaging, Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Otol Neurotol. 2014 Jan;35(1):121-5. doi: 10.1097/MAO.0000000000000234.
To investigate a correlation between preoperative non-echo planar diffusion-weighted magnetic resonance imaging (non-EPI DW MRI) with surgical findings of localization and extension of cholesteatoma and to develop criteria for surgical planning.
Preoperative non-EPI DWMRI was available and positive for cholesteatoma in 27 patients with primary and 23 with residual/recurrent lesions.
Patients with cholesteatoma limited to the middle ear and its extensions were managed with a transcanal endoscopic approach. Patients with extension of the cholesteatoma posteriorly to the lateral semicircular canal underwent retroauricular mastoidectomy combined with an endoscopic approach.
Comparison of preoperative radiologic to surgical findings.
DWI showed isolated tympanic and attic extension in 33 cases and attico-antral and mastoid extension in 17 cases. MRI findings correlated with surgical findings in all patients with primary cholesteatoma, 19 of whom were managed with a transcanal endoscopic approach and 8 with endoscope-assisted ear surgery. The transcanal endoscopic approach was applied in 14 of the patients with residual/recurrent cholesteatoma, and the other 9 residual/recurrent lesions were eradicated using endoscope-assisted mastoidectomy. DWI overestimated cholesteatoma sites in 1 patient with residual lesion. The smallest cholesteatoma detected on DWI was a 3-mm lesion in the middle ear over the facial nerve.
Primary and residual/recurrent cholesteatoma was accurately detected on non-EPI DWI with 98% clinical and radiologic concordance. Lesions less than 8 mm confined to the middle ear and its extensions can be eradicated with a minimally invasive endoscopic transcanal technique, whereas endoscope-assisted retroauricular mastoidectomy is preferred for larger lesions.
探讨术前非 EPI 弥散加权磁共振成像(non-EPI DW MRI)与胆脂瘤定位和扩展的手术发现之间的相关性,并制定手术规划的标准。
27 例原发性和 23 例残余/复发性病变患者的术前非 EPI DWMRI 可及且胆脂瘤阳性。
胆脂瘤局限于中耳及其延伸的患者采用经耳道内镜入路治疗。胆脂瘤向后延伸至外半规管的患者行耳后乳突切除术,结合内镜入路。
术前影像学与手术发现的比较。
DWI 显示单纯鼓室和 attic 延伸 33 例,attico-antral 和 mastoid 延伸 17 例。所有原发性胆脂瘤患者的 MRI 发现均与手术发现相符,其中 19 例采用经耳道内镜入路治疗,8 例采用内镜辅助耳手术。经耳道内镜入路应用于 14 例残余/复发性胆脂瘤患者,另 9 例残余/复发性病变采用内镜辅助乳突切除术根除。1 例残余病变患者 DWI 高估了胆脂瘤部位。DWI 检测到的最小胆脂瘤位于面神经上方中耳的 3mm 病变。
非 EPI DWI 可准确检测原发性和残余/复发性胆脂瘤,临床和影像学符合率为 98%。病变小于 8mm 局限于中耳及其延伸者可采用微创内镜经耳道技术根除,而较大病变则首选内镜辅助耳后乳突切除术。